ARTICLE | Company News
Caprion in-licenses CAP-232
March 15, 2006 2:19 AM UTC
Caprion (Montreal, Quebec) in-licensed CAP-232 ( TT-232) from technology transfer company Expergen (Vienna, Austria) for an undisclosed amount of stock and cash. The heptapeptide, which targets pyruva...